DVA: We Are Removing DaVita from Investing Ideas

09/24/19 11:06AM EDT

A quick note from Hedgeye CEO Keith McCullough:

Post Chanos giving me an out, I’ll take even money on this one and wait to re-load on the next squeeze. From a quantitative signaling #process perspective, DVA is still Bullish @Hedgeye TREND.

***No change to Healthcare analyst Tom Tobin's fundamental short thesis on DaVita (DVA). Click here to read our analyst's original report.

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.